ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Internal Medicine

Top Internal Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BENJAMIN BENNOV MD

Internal Medicine

45,615

$3.22M

685
602 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 25%

$71
Average prescription price

Avg: $58

MIKHAIL AZRILEVICH MD

Internal Medicine

43,217

$2.58M

681
609 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

39%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $58

YITZCHOK KURTZER MD

Internal Medicine

35,064

$2.15M

1258
793 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $58

SURINDER BAJWA MD

Internal Medicine

34,341

$1.92M

1343
1118 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $58

YEVGENIY GOLDMAN MD

Internal Medicine

33,420

$2.12M

597
546 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $58

DALJIT SINGH M.D.

Internal Medicine

33,076

$1.95M

1300
1101 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $58

YOGINDRA BALHARA MD

Internal Medicine

30,959

$1.61M

606
507 are 65+

25%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $58

KAUSHIK PATEL M.D.

Internal Medicine

30,522

$1.5M

873
595 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $58

ALLA SHPANER M.D.

Internal Medicine

30,333

$1.78M

469
434 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $58

ROBERT DURAKO DO

Internal Medicine

30,237

$1.62M

641
564 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

22%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $58

STEVEN GABRIEL MD

Internal Medicine

29,410

$1.56M

787
599 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $58

CHARLES ACKLEY D.O.

Internal Medicine

29,076

$1.12M

803
699 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$38
Average prescription price

Avg: $58

ALAKANANDA CHAKRABARTY MD

Internal Medicine

29,064

$1.77M

663
530 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $58

MERI KRYSS MD

Internal Medicine

28,467

$2.06M

327
298 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $58

CAREY MCMONAGLE M.D.

Internal Medicine

28,376

$1.26M

1055
909 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $58

CHERIAN JOHN MD

Internal Medicine

28,082

$1.27M

1433
1159 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $58

BARRY MINORA MD

Internal Medicine

27,819

$1.3M

563
439 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

23%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $58

MAX MERCADO M.D.

Internal Medicine

27,815

$2.31M

682
450 are 65+

22%
patients receiving schedule two controlled substances

Avg: 7%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $58

WAYNE MILLER MD

Internal Medicine

27,659

$1.42M

741
609 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

4%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $58

SILVIA COLEMAN MD

Internal Medicine

27,619

$1.48M

877
699 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $58

LEONID MAGIDENKO MD

Internal Medicine

26,970

$1.69M

401
348 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $58

BALKISSOON MAHARAJH MD

Internal Medicine

26,377

$1.55M

648
608 are 65+

17%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $58

NGOC AN PHAN M.D.

Internal Medicine

26,070

$2.61M

346
309 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

21%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 25%

$100
Average prescription price

Avg: $58

MATTHEW KLAIN MD

Internal Medicine

25,765

$1.61M

1255
997 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $58

KENNETH SEBASTIANELLI MD

Internal Medicine

25,712

$1.2M

841
708 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank